This website is for UK and Ireland Healthcare professionals only.

If you are not a healthcare professional in the UK, please click here.

If you are not a healthcare professional in Ireland, please click here.

Eliquis® (apixaban)

Risk Minimisation Information for Healthcare Professionals

Reporting suspected adverse reactions to apixaban

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

UK:

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Ireland:

Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance at www.hpra.ie.

Adverse events may also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK); 1 800 749 749 (Ireland).

If you require any further information regarding the use of apixaban, please contact Bristol-Myers Squibb Medical Information.

When reporting, please provide as much information as possible, including information on medical history, any concomitant medication, onset and treatment dates.